A Phase Ib/II Study to Evaluate Multiple Combination Therapies of FWD1802 in Patients With ER+/HER2- BC

Clinical trial NCT07002177 · RECRUITING

Trial details

NCT number: NCT07002177
Sponsor: Forward Pharmaceuticals Co., Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Metastatic Breast Cancer Breast Cancer Stage I Breast Cancer Stage II Locally Advanced Breast Cancer (LABC)ER+ Breast Cancer

Start date: 2025-06-01
Primary completion: 2028-05-01
Enrollment: 196

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.